Clinical Trial Update: Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis [NA]

View source ↗

Summary

This update notes the completion of an open-label vitamin D trial in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis and that results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis
• Cystic Fibrosis

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: University of Pittsburgh | Conditions: Cystic Fibrosis, Allergic Bronchopulmonary Aspergillosis | NA | Status: COMPLETED | Results posted: 2018-03-29